Terms: = Prostate cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716 AND Treatment
22 results:
1. Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the jak1/STAT4 pathway.
Cheng B; Li L; Luo T; Wang Q; Luo Y; Bai S; Li K; Lai Y; Huang H
J Exp Clin Cancer Res; 2024 Mar; 43(1):67. PubMed ID: 38429845
[TBL] [Abstract] [Full Text] [Related]
2. Dieckol prevents prostate cancer cell proliferation by transcriptionally attenuating JAK/STAT3 signaling pathway.
Karuppaiya V; Annamalai A; Krishnamurthy S; Soundarapandian K
Environ Toxicol; 2024 Mar; 39(3):1187-1196. PubMed ID: 37886886
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells.
Nalairndran G; Chung I; Abdul Razack AH; Chung FF; Hii LW; Lim WM; Looi CK; Mai CW; Leong CO
J Cell Mol Med; 2021 Sep; 25(17):8187-8200. PubMed ID: 34322995
[TBL] [Abstract] [Full Text] [Related]
4. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.
Jung YY; Ko JH; Um JY; Chinnathambi A; Alharbi SA; Sethi G; Ahn KS
J Cell Physiol; 2021 Jul; 236(7):5253-5264. PubMed ID: 33368314
[TBL] [Abstract] [Full Text] [Related]
5. An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic prostate cancer.
Dawson NA; Zibelman M; Lindsay T; Feldman RA; Saul M; Gatalica Z; Korn WM; Heath EI
Mol Cancer Ther; 2020 Jun; 19(6):1373-1382. PubMed ID: 32220973
[TBL] [Abstract] [Full Text] [Related]
6. Attenuation of STAT3 Signaling Cascade by Daidzin Can Enhance the Apoptotic Potential of Bortezomib against Multiple Myeloma.
Yang MH; Jung SH; Chinnathambi A; Alahmadi TA; Alharbi SA; Sethi G; Ahn KS
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31878046
[TBL] [Abstract] [Full Text] [Related]
7. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer.
Lee JH; Kim C; Baek SH; Ko JH; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
Oncotarget; 2017 Mar; 8(11):17700-17711. PubMed ID: 27458171
[TBL] [Abstract] [Full Text] [Related]
8. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection.
Danziger O; Shai B; Sabo Y; Bacharach E; Ehrlich M
Oncotarget; 2016 Aug; 7(32):52115-52134. PubMed ID: 27366948
[TBL] [Abstract] [Full Text] [Related]
9. SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in prostate cancer Cells.
Handle F; Erb HH; Luef B; Hoefer J; Dietrich D; Parson W; Kristiansen G; Santer FR; Culig Z
Mol Cancer Res; 2016 Jun; 14(6):574-85. PubMed ID: 27053681
[TBL] [Abstract] [Full Text] [Related]
10. N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells.
Wang X; Breeze A; Kulka M
Cancer Immunol Immunother; 2015 Feb; 64(2):249-58. PubMed ID: 25351720
[TBL] [Abstract] [Full Text] [Related]
11. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
[TBL] [Abstract] [Full Text] [Related]
12. Pharmacologic suppression of jak1/2 by jak1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation.
Gu L; Talati P; Vogiatzi P; Romero-Weaver AL; Abdulghani J; Liao Z; Leiby B; Hoang DT; Mirtti T; Alanen K; Zinda M; Huszar D; Nevalainen MT
Mol Cancer Ther; 2014 May; 13(5):1246-58. PubMed ID: 24577942
[TBL] [Abstract] [Full Text] [Related]
13. Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.
Seo HK; Ahn KO; Jung NR; Shin JS; Park WS; Lee KH; Lee SJ; Jeong KC
Oncotarget; 2014 Jan; 5(2):326-37. PubMed ID: 24504118
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxia preconditioning of mesenchymal stromal cells enhances PC3 cell lymphatic metastasis accompanied by VEGFR-3/CCR7 activation.
Huang X; Su K; Zhou L; Shen G; Dong Q; Lou Y; Zheng S
J Cell Biochem; 2013 Dec; 114(12):2834-41. PubMed ID: 23939705
[TBL] [Abstract] [Full Text] [Related]
15. β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase.
Kim C; Cho SK; Kapoor S; Kumar A; Vali S; Abbasi T; Kim SH; Sethi G; Ahn KS
Mol Carcinog; 2014 Oct; 53(10):793-806. PubMed ID: 23765383
[TBL] [Abstract] [Full Text] [Related]
16. Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis.
Prasad S; Pandey MK; Yadav VR; Aggarwal BB
Cancer Prev Res (Phila); 2011 Jul; 4(7):1084-94. PubMed ID: 21490133
[TBL] [Abstract] [Full Text] [Related]
17. Ruxolitinib, a selective jak1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis.
Mesa RA
IDrugs; 2010 Jun; 13(6):394-403. PubMed ID: 20506062
[TBL] [Abstract] [Full Text] [Related]
18. Identification of inactivating mutations in the jak1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis.
Rossi MR; Hawthorn L; Platt J; Burkhardt T; Cowell JK; Ionov Y
Cancer Genet Cytogenet; 2005 Sep; 161(2):97-103. PubMed ID: 16102578
[TBL] [Abstract] [Full Text] [Related]
19. IFN unresponsiveness in LNCaP cells due to the lack of jak1 gene expression.
Dunn GP; Sheehan KC; Old LJ; Schreiber RD
Cancer Res; 2005 Apr; 65(8):3447-53. PubMed ID: 15833880
[TBL] [Abstract] [Full Text] [Related]
20. Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines.
Barton BE; Murphy TF; Shu P; Huang HF; Meyenhofer M; Barton A
Mol Cancer Ther; 2004 Oct; 3(10):1183-91. PubMed ID: 15486184
[TBL] [Abstract] [Full Text] [Related]
[Next]